About Perceive Bio
Perceive Bio is a company based in San Francisco (United States) founded in 2021 by Anne Rubin.. Perceive Bio has raised $78 million across 1 funding round from investors including Johnson & Johnson Innovation, Deerfield and Retinal Degeneration Fund. Perceive Bio offers products and services including Pipeline Assets, Therapeutics for Dry AMD, and Neuroprotection Therapies. Perceive Bio operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter San Francisco, United States
- Founders Anne Rubin
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perceive Biotherapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$78 M (USD)
in 1 rounds
-
Latest Funding Round
$78 M (USD), Series B
Jan 05, 2023
-
Investors
Johnson & Johnson Innovation
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Perceive Bio
Perceive Bio offers a comprehensive portfolio of products and services, including Pipeline Assets, Therapeutics for Dry AMD, and Neuroprotection Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for dry AMD and retinal neuroprotection via biological innovations
Targets dry age-related macular degeneration to prevent vision loss
Focuses on protecting retinal cells from degeneration through research
Unlock access to complete
Funding Insights of Perceive Bio
Perceive Bio has successfully raised a total of $78M through 1 strategic funding round. The most recent funding activity was a Series B round of $78 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $78.0M
-
First Round
First Round
(05 Jan 2023)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series B - Perceive Bio | Valuation | Johnson & Johnson Innovation |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perceive Bio
Perceive Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation, Deerfield and Retinal Degeneration Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Investments are focused on retinal degeneration therapeutic solutions.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perceive Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perceive Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perceive Bio Comparisons
Competitors of Perceive Bio
Perceive Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perceive Bio
Frequently Asked Questions about Perceive Bio
When was Perceive Bio founded?
Perceive Bio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Perceive Bio located?
Perceive Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Perceive Bio?
K Angela Macfarlane is the current CEO of Perceive Bio.
Is Perceive Bio a funded company?
Perceive Bio is a funded company, having raised a total of $78M across 1 funding round to date. The company's 1st funding round was a Series B of $78M, raised on Jan 05, 2023.
What does Perceive Bio do?
Perceive Bio was founded in 2021 and is headquartered in San Francisco, United States. Therapeutics are developed by the company to address diabetes and various eye diseases. A pipeline of drugs is being advanced for conditions including retinal degeneration, dry age-related macular degeneration, neuroprotection, and central nervous system disorders. Operations focus on biotechnology research and drug development in the healthcare sector.
Who are the top competitors of Perceive Bio?
Perceive Bio's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Perceive Bio offer?
Perceive Bio offers Pipeline Assets, Therapeutics for Dry AMD, and Neuroprotection Therapies.
Who are Perceive Bio's investors?
Perceive Bio has 5 investors. Key investors include Johnson & Johnson Innovation, Deerfield, Retinal Degeneration Fund, Catalio Capital Management, and Braidwell.